Recent 8-K filings for MDLN

• August 5, 2026, 7:34 AM ET earnings materiality 0.75 neutral item 2.02item 9.01

  Medline Q2 net sales up 11.6% to $7.7B; net income down 58.3%; updates FY guidance

  Q2 net sales $7.7B (+11.6% YoY); net income $139M (-58.3%); diluted EPS $0.07, adjusted EPS $0.50.

• July 9, 2026, 4:00 PM ET leadership materiality 0.65 negative item 5.02

  Medline COO Stephen L. Miller to retire Aug 30 for health reasons; search underway

  COO Stephen L. Miller notified company of retirement effective August 30, 2026, citing health reasons.

• June 2, 2026, 8:06 AM ET debt materiality 0.75 neutral item 1.01item 2.03item 8.01item 9.01 ◈ Material Agreements ×2

  Medline issues $2.0B senior secured notes & refinances $2.75B term loan; secondary offering of 72.6M shares at $37

  Issued $1.25B of 5.000% senior secured notes due 2031 and $750M of 5.250% senior secured notes due 2033.

• May 6, 2026, 7:59 PM ET earnings materiality 0.75 negative item 2.02item 9.01 ◈ Earnings Releases

  Medline Q1 sales up 10.7% to $7.4B; net income down 25.8%, adjusted EBITDA down 10.6%

  Net income $239M (-25.8% YoY); Diluted EPS $0.16; Adjusted Diluted EPS $0.33.

• February 25, 2026, 6:59 PM ET earnings materiality 0.75 negative item 2.02item 9.01

  Medline Q4 net income down 37.7% to $180M; FY25 EBITDA up 3.2%; guides FY26 organic sales growth 8-9%

  Q4 net sales $7.8B (+14.8% YoY); net income $180M (-37.7%); Adj. EBITDA $805M (flat).

• December 22, 2025, 6:59 PM ET other material materiality 0.60 neutral item 1.01item 3.03item 5.03item 5.02item 8.01item 9.01 ◈ Material Agreements ×9◈ Governance Changes ×2

  Medline completes IPO of ~248M shares at $29; uses proceeds to repay debt and buy out pre-IPO owners

  IPO closed Dec 18, 2025: 248,439,654 shares of Class A common stock at $29.00 per share.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.75 · Median 0.75 · Most common event earnings

0 positive 3 negative 4 neutral

source · MDLN on sec.gov